Search

Your search keyword '"Anne-Sophie Rebillat"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Anne-Sophie Rebillat" Remove constraint Author: "Anne-Sophie Rebillat"
43 results on '"Anne-Sophie Rebillat"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Transcriptomic study in women with trisomy 21 identifies a possible role of the GTPases of the immunity-associated proteins (GIMAP) in the protection of breast cancer

3. Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome

4. DYRK1A and Activity-Dependent Neuroprotective Protein Comparative Diagnosis Interest in Cerebrospinal Fluid and Plasma in the Context of Alzheimer-Related Cognitive Impairment in Down Syndrome Patients

5. Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

6. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease

7. COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated

8. Molecular Rescue of Dyrk1A Overexpression Alterations in Mice with Fontup® Dietary Supplement: Role of Green Tea Catechins

10. Acute Regression in Young People with Down Syndrome

11. Autoimmunity in Down’s syndrome via cytokines, CD4 T cells and CD11c+ B cells

12. Innovating Therapies for Down Syndrome: An International Virtual Conference of the T21 Research Society

13. The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation1

14. Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome

15. Transcriptomic study in women with trisomy 21 identifies a possible role of the GTPases of the immunity-associated proteins (GIMAP) in the protection of breast cancer

16. COVID-19 Vaccination of Individuals With Down Syndrome – Data From the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated With the Decision to Get Vaccinated

17. Accelerated biological aging in people with Down syndrome with full and segmental trisomy 21 begins in childhood as revealed by immunoglobulin G glycosylation

18. The COVID-19 pandemic should be last orders for poor care of people with neurodevelopmental disorders

19. The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease

20. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

21. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

22. Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease

23. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study

24. Effect of Exergaming on Physical Fitness, Functional Mobility, and Cognitive Functioning in Adults With Down Syndrome

25. The French translation of the dementia screening questionnaire for individuals with intellectual disabilities is a sensitive tool for screening for dementia in people with Down Syndrome

26. Diagnostic lumbar puncture in people with Down syndrome: The experience of the Jerome Lejeune Institute

28. Longitudinal plasma levels of neurofilament light in Down syndrome: A multicenter study

29. An international survey on the impact of COVID-19 in individuals with Down syndrome

30. Additional file 2 of Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome

31. Additional file 1 of Ultrastructural and dynamic studies of the endosomal compartment in Down syndrome

32. ]Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic Findings

33. Prevalence and Description of Hidradenitis Suppurativa in Down Syndrome: A Cross-sectional Study of 783 Subjects

34. Acute Regression in Young People with Down Syndrome

35. PKR downregulation prevents neurodegeneration and β-amyloid production in a thiamine-deficient model

36. P4‐223: PKR DOWN‐REGULATION DECREASES NEURODEGENERATION AND B‐AMYLOID PRODUCTION

37. P2–380: Role of PKR in a mouse model of neuronal degeneration linked to oxidative stress

38. Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice

39. Neuroprotective role of PKR in a model of neurodegeneration due to mild impairment of oxidative metabolism

40. Behavioural and psychological symptoms of dementia in Down syndrome: European development of the novel BPSD-DS evaluation scale

41. P3‐408: A french innovative department dedicated to Alzheimer's disease patients

42. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

43. Effect of Exergaming on Physical Fitness, Functional Mobility, and Cognitive Functioning in Adults With Down Syndrome.

Catalog

Books, media, physical & digital resources